HK1208381A1 - Hutc modulation of pro-inflammatory mediators of lung and pulmonary diseases and disorders hutc - Google Patents

Hutc modulation of pro-inflammatory mediators of lung and pulmonary diseases and disorders hutc

Info

Publication number
HK1208381A1
HK1208381A1 HK15109248.4A HK15109248A HK1208381A1 HK 1208381 A1 HK1208381 A1 HK 1208381A1 HK 15109248 A HK15109248 A HK 15109248A HK 1208381 A1 HK1208381 A1 HK 1208381A1
Authority
HK
Hong Kong
Prior art keywords
hutc
lung
disorders
pro
modulation
Prior art date
Application number
HK15109248.4A
Other languages
English (en)
Chinese (zh)
Inventor
Anthony J Kihm
Original Assignee
Depuy Synthes Products Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Depuy Synthes Products Llc filed Critical Depuy Synthes Products Llc
Publication of HK1208381A1 publication Critical patent/HK1208381A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK15109248.4A 2012-05-14 2015-09-21 Hutc modulation of pro-inflammatory mediators of lung and pulmonary diseases and disorders hutc HK1208381A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/471,095 US20130302283A1 (en) 2012-05-14 2012-05-14 hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS
PCT/US2013/041002 WO2013173376A1 (en) 2012-05-14 2013-05-14 hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS

Publications (1)

Publication Number Publication Date
HK1208381A1 true HK1208381A1 (en) 2016-03-04

Family

ID=48577869

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15109248.4A HK1208381A1 (en) 2012-05-14 2015-09-21 Hutc modulation of pro-inflammatory mediators of lung and pulmonary diseases and disorders hutc

Country Status (18)

Country Link
US (1) US20130302283A1 (ja)
EP (1) EP2854825B1 (ja)
JP (2) JP6647863B2 (ja)
KR (2) KR20150009586A (ja)
CN (1) CN104736160A (ja)
AU (1) AU2013262946B2 (ja)
BR (1) BR112014028409A2 (ja)
CA (1) CA2872591C (ja)
ES (1) ES2702349T3 (ja)
HK (1) HK1208381A1 (ja)
IN (1) IN2014DN09084A (ja)
MX (1) MX366152B (ja)
PH (1) PH12014502508A1 (ja)
PL (1) PL2854825T3 (ja)
RU (1) RU2668389C2 (ja)
SG (2) SG10201804052UA (ja)
WO (1) WO2013173376A1 (ja)
ZA (1) ZA201409184B (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120156134A1 (en) 2007-12-20 2012-06-21 Shayne Squires Compositions and methods for detecting or eliminating senescent cells to diagnose or treat disease
CA2747794C (en) 2008-12-19 2018-10-30 Advanced Technologies And Regenerative Medicine, Llc Treatment of lung and pulmonary diseases and disorders
WO2012177927A1 (en) 2011-06-21 2012-12-27 Mayo Foundation For Medical Education And Research Transgenic animals capable of being induced to delete senescent cells
MX2014007093A (es) 2011-12-13 2014-10-13 Buck Inst For Res On Aging Metodos para mejorar terapias medicas.
WO2013158664A2 (en) 2012-04-17 2013-10-24 Kythera Biopharmaceuticals, Inc. Use of engineered viruses to specifically kill senescent cells
US9901080B2 (en) 2012-08-23 2018-02-27 Buck Institute For Research On Aging Transgenic mouse having a transgene that converts a prodrug into a cytotoxic compound in senescent cells
US9901081B2 (en) 2012-08-23 2018-02-27 Buck Institute For Research On Aging Transgenic mouse for determining the role of senescent cells in cancer
US10279018B2 (en) 2012-12-03 2019-05-07 Unity Biotechnology, Inc. Immunogenic compositions for inducing an immune response for elimination of senescent cells
AU2015211021B2 (en) 2014-01-28 2020-07-02 Buck Institute For Research On Aging Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders
US10328058B2 (en) 2014-01-28 2019-06-25 Mayo Foundation For Medical Education And Research Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques
WO2015116735A1 (en) 2014-01-28 2015-08-06 Mayo Foundation For Medical Education And Research Methods and combinations for killing senescent cells and for treating senescence-associated diseases and disorders
CN105420184A (zh) * 2015-12-11 2016-03-23 郭镭 一种从脐带外层羊膜组织中分离培养脐带间充质干细胞的方法
CN105462919A (zh) * 2015-12-11 2016-04-06 郭镭 一种从脐带华通氏胶组织中分离提取hUC-MSC的方法
WO2017096607A1 (zh) * 2015-12-11 2017-06-15 郭镭 一种从脐带外层羊膜组织中分离提取hUC-MSC的方法
WO2017096615A1 (zh) * 2015-12-11 2017-06-15 郭镭 一种从脐带华通氏胶组织中分离提取hUC-MSC的方法
WO2017096618A1 (zh) * 2015-12-11 2017-06-15 郭镭 一种从脐带外层羊膜组织中分离培养脐带间充质干细胞的方法
EP3388512B1 (en) * 2015-12-11 2023-08-23 Lei Guo Method for separating and culturing mesenchymal stem cells from wharton's jelly tissue of umbilical cord
CN105420185A (zh) * 2015-12-11 2016-03-23 郭镭 一种从脐带外层羊膜组织中分离提取hUC-MSC的方法
WO2019083995A1 (en) * 2017-10-23 2019-05-02 Cell Medicine, Inc. MESENCHYMAL STEM CELL THERAPY OF LEIGH SYNDROME
CA3115291A1 (en) * 2018-10-05 2020-04-09 Board Of Regents, The University Of Texas System Methods for the expansion of mesenchymal stromal cells
US11975030B2 (en) 2019-03-19 2024-05-07 Figene, Llc Treatment of chronic obstructive pulmonary disease and lung degeneration using activated fibroblasts and exosome derivatives thereof
US20230091910A1 (en) * 2019-04-02 2023-03-23 Centagen, Inc. Engineered System of Stem Cell Rejuvenation to Treat Aging and Disease
CN110923308A (zh) * 2019-12-12 2020-03-27 河南师范大学 特发性肺纤维化疾病诊断标志物及其制备诊断或预后工具中的应用
WO2021183774A1 (en) * 2020-03-12 2021-09-16 Angion Biomedica Corp. Treating acute respiratory distress
CN112511569B (zh) * 2021-02-07 2021-05-11 杭州筋斗腾云科技有限公司 网络资源访问请求的处理方法、系统及计算机设备

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955343A (en) 1992-12-28 1999-09-21 Massachusetts Institute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5670483A (en) 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US6610540B1 (en) 1998-11-18 2003-08-26 California Institute Of Technology Low oxygen culturing of central nervous system progenitor cells
KR100696408B1 (ko) 1999-04-16 2007-03-19 더블유엠. 마쉬 라이스 유니버시티 폴리(에틸렌글리콜)과 가교결합을 이룬 폴리(프로필렌푸마레이트)
US6355699B1 (en) 1999-06-30 2002-03-12 Ethicon, Inc. Process for manufacturing biomedical foams
US6555374B1 (en) 1999-08-19 2003-04-29 Artecel Sciences, Inc. Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof
US7723296B2 (en) 2001-01-18 2010-05-25 Genzyme Corporation Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
US7449180B2 (en) 2001-02-06 2008-11-11 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
WO2002062961A2 (en) 2001-02-06 2002-08-15 Massachusetts Institute Of Technology Peptide scaffold encapsulation of tissue cells and uses thereof
US9969980B2 (en) 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
US9969977B2 (en) 2002-09-20 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
JP5148873B2 (ja) * 2003-06-27 2013-02-20 エチコン、インコーポレイテッド 臍帯組織由来の分娩後細胞、及びその作成及び使用方法
BRPI0921999B8 (pt) * 2008-11-21 2021-05-25 Anthrogenesis Corp uso de uma quantidade terapeuticamente eficaz de células tronco placentárias
CA2747794C (en) * 2008-12-19 2018-10-30 Advanced Technologies And Regenerative Medicine, Llc Treatment of lung and pulmonary diseases and disorders
AU2010229651B2 (en) * 2009-03-26 2014-05-08 Advanced Technologies And Regenerative Medicine, Llc Human umbilical cord tissue cells as therapy for Alzheimer' s disease
DK2624847T3 (en) * 2010-10-05 2017-10-09 Aal Scient Inc HUMAN LUNG STEM CELLS AND APPLICATIONS THEREOF

Also Published As

Publication number Publication date
WO2013173376A1 (en) 2013-11-21
SG10201804052UA (en) 2018-07-30
CA2872591A1 (en) 2013-11-21
EP2854825A1 (en) 2015-04-08
AU2013262946A1 (en) 2015-01-22
CA2872591C (en) 2021-11-30
ZA201409184B (en) 2017-06-28
IN2014DN09084A (ja) 2015-05-22
EP2854825B1 (en) 2018-10-31
SG11201407376SA (en) 2015-03-30
MX366152B (es) 2019-06-28
PH12014502508B1 (en) 2014-12-22
JP2018118984A (ja) 2018-08-02
MX2014014027A (es) 2015-02-10
JP6779931B2 (ja) 2020-11-04
KR20180136560A (ko) 2018-12-24
ES2702349T3 (es) 2019-02-28
RU2014150508A (ru) 2016-07-10
RU2668389C2 (ru) 2018-09-28
JP6647863B2 (ja) 2020-02-14
BR112014028409A2 (pt) 2018-07-24
AU2013262946B2 (en) 2018-02-01
PH12014502508A1 (en) 2014-12-22
CN104736160A (zh) 2015-06-24
JP2015518830A (ja) 2015-07-06
PL2854825T3 (pl) 2019-04-30
US20130302283A1 (en) 2013-11-14
KR20150009586A (ko) 2015-01-26

Similar Documents

Publication Publication Date Title
HK1208381A1 (en) Hutc modulation of pro-inflammatory mediators of lung and pulmonary diseases and disorders hutc
HK1211844A1 (en) Treatment of pulmonary disease
PT3027738T (pt) Mscs no tratamento de doenças pulmonares inflamatórias
HK1214832A1 (zh) 用於代謝病症和疾病治療的組合物和方法
HK1201452A1 (en) Methods of reducing risk of cardiovascular disease
EP2911892A4 (en) Collapsible wheels and methods of making collapsible wheels
EP2710370A4 (en) METHODS OF DIAGNOSING AND TREATING PULMONARY DISEASES OR DISORDERS
HUE041553T2 (hu) Lizoszomális tárolási betegségek (LSD) kezelése és génterápia
HK1198909A1 (en) Compositions and methods for the treatment of hepatic diseases and disorders
EP2844903A4 (en) TUBES AND METHOD FOR THE PRODUCTION AND USE THEREOF
SI3626270T1 (sl) Zdravljenje srčno-žilnih bolezni
HK1211213A1 (en) Treatment of diseases involving mucin
HK1204573A1 (en) Treatment of inflammatory skin disorders
ZA201500547B (en) Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases
PL2892556T3 (pl) Kompozycje i sposoby odnoszące się do leczenia chorób
EP2673363A4 (en) TREATMENT OF ANGIOGENESIS DISORDERS
ZA201500488B (en) Manufacture of wheels
EP3030261A4 (en) Methods of treatment of hpv related diseases
EP2919773A4 (en) METHOD FOR THE TREATMENT OF KERATINOCYTE-MEDIATED LESIONS
GB201201778D0 (en) Treatment of inflammatory respiratory disease
GB201201779D0 (en) Treatment of inflammatory disorders
AU2012902874A0 (en) Treatment of inflammatory skin disorders
GB201219092D0 (en) Treatment of cardiovascular disease
AU2012901301A0 (en) Treatment of inflammatory and immune disorders
AU2012905519A0 (en) Treatment of diseases involving mucin

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230511